Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


June 02, 2015 8:03 PM ET

Pharmaceuticals

Company Overview of PMV Pharmaceuticals, Inc.

Company Overview

PMV Pharmaceuticals, Inc. is engaged in the discovery and development of p53 targeted small molecule drugs for the treatment of cancer and infectious disease. The company was founded in 2013 and is based in Redwood City, California with scientific research and development facilities in Doylestown, Pennsylvania.

497 Seaport Court

Suite 101

Redwood City, CA 94063

United States

Founded in 2013

Key Executives for PMV Pharmaceuticals, Inc.

Co-Founder, Chief Executive Officer, President and Director
Age: 52
Co-Founder, Director and Member of Scientific Advisory Board
Age: 74
Co-Founder and Member of Scientific Advisory Board
Age: 67
Vice President of Preclinical Discovery
Compensation as of Fiscal Year 2014.

PMV Pharmaceuticals, Inc. Key Developments

PMV Pharmaceuticals, Inc. Presents at Boston CEO Conference, May-26-2015 03:00 PM

PMV Pharmaceuticals, Inc. Presents at Boston CEO Conference, May-26-2015 03:00 PM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, United States. Speakers: David H. Mack, Co-Founder, Chief Executive Officer, President and Director.

PMV Pharmaceutcals, Inc. Appoints Steven H. Holtzman to the Board of Directors

PMV Pharmaceutcals, Inc. announced the appointment of Steven Holtzman to the board of directors. Mr. Holtzman's appointment brings the total board to five members as he joins current members Arnold Levine, Ph.D., David Mack, Ph.D., Arnold Oronsky, Ph.D. and Douglas Fisher, M.D. Steve Holtzman currently serves as Executive Vice President, Corporate Development for Biogen Idec where he is responsible for Business Development and M&A, and Program Leadership & Management of the company's late-stage product candidates and marketed products. Prior to joining Biogen Idec, Mr. Holtzman served as the Founder, CEO and Chair of the Board of Directors of Infinity Pharmaceuticals, Inc.

Similar Private Companies By Industry

Company Name Region
United Medical Industrial Group, Inc. United States
Global Marketing Associates, Inc. United States
Imagen Biotech, Inc. United States
Warner Chilcott, Inc. United States
RXNB Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
December 2, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PMV Pharmaceuticals, Inc., please visit www.pmvpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.